Different Heparan Sulfate Proteoglycans Serve as Cellular Receptors for Human Papillomaviruses

Journal of Virology

Volumn 77, Issue 24, 2003, Pages 13125-13135

  Shafti Keramat, Saeed ^a   Handisurya, Alessandra ^a   Kriehuber, Ernst ^b   Meneguzzi, Guerrino ^c   Slupetzky, Katharina ^a   Kirnbauer, Reinhard ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; CELL RECEPTOR; GLYPICAN; GLYPICAN 1; PHOSPHOLIPASE C; PROTEOHEPARAN SULFATE; RECEPTOR PROTEIN; SYNDECAN; SYNDECAN 1; SYNDECAN 4; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SKIN EPITHELIUM; UPREGULATION; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS REPLICATION; VIRUS STRAIN; WART VIRUS;

HEPARAN SULFATE PROTEOGLYCANS; HUMANS; K562 CELLS; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; PAPILLOMAVIRIDAE; PROTEOGLYCANS; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; SYNDECAN-1; SYNDECAN-4; SYNDECANS; TRANSFECTION; VIRION;

EID: 0345599103     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.24.13125-13135.2003     Document Type: Article

References (57)

1. Attisano, L., J. L. Wrana, F. Lopez-Casillas, and J. Massague. 1994. TGF-beta receptors and actions. Biochim. Biophys. Acta 1222:71-80.
2. Bernfield, M., M. Gotte, P. W. Park, O. Reizes, M. L. Fitzgerald, J. Lincecum, and M. Zako. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:729-777.
3. Bernfield, M., M. T. Hinkes, and R. L. Gallo. 1993. Developmental expression of the syndecans: possible function and regulation. Development 1993(Suppl.):205-212.
4. Bousarghin, L., A. Touze, P. Y. Sizaret, and P. Coursaget. 2003. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 77:3846-3850.
5. Bryan, J. T., and D. R. Brown. 2001. Transmission of human papillomavirus type 11 infection by desquamated cornified cells. Virology 281:35-42.
6. Byrnes, A. P., and D. E. Griffin. 1998. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:7349-7356.
7. Chen, X. S., R. L. Garcea, I. Goldberg, G. Casini, and S. C. Harrison. 2000. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5:557-567.
8. Christensen, N., J. Dillner, C. Eklund, J. Carter, G. Wipf, C. Reed, N. Cladel, and D. Galloway. 1996. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223:174-184.
9. Christensen, N. D., and J. W. Kreider. 1990. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J. Virol. 64:3151-3156.
10. Christensen, N. D., J. W. Kreider, N. M. Cladel, S. D. Patrick, and P. A. Welsh. 1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:5678-5681.
11. Christensen, N. D., C. A. Reed, T. D. Culp, P. L. Hermonat, M. K. Howett, R. A. Anderson, and L. J. Zaneveld. 2001. Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob. Agents Chemother. 45:3427-3432.
12. David, G., B. van der Schueren, P. Marynen, J. J. Cassiman, and H. van den Berghe. 1992. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J. Cell Biol. 118:961-969.
13. Day, P. M., D. R. Lowy, and J. T. Schiller. 2003. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307:1-11.
14. Elenius, K., S. Vainio, M. Laato, M. Salmivirta, I. Thesleff, and M. Jalkanen. 1991. Induced expression of syndecan in healing wounds. J. Cell Biol. 114:585-595.
15. Evander, M., I. H. Frazer, E. Payne, Y. M. Qi, K. Hengst, and N. A. McMillan. 1997. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol. 71:2449-2456.
16. Gache, Y., C. Romero-Graillet, A. Spadafora, C. Lepinard, P. Descamps, C. B. Bardon, J. P. Ortonne, and G. Meneguzzi. 1998. A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination. J. Investig. Dermatol. 111:914-916.
17. Giroglou, T., L. Florin, F. Schafer, R. E. Streeck, and M. Sapp. 2001. Human papillomavirus infection requires cell surface heparan sulfate J. Virol. 75:1565-1570.
18. Harro, C. D., Y. Y. Pang, R. B. Roden, A. Hildesheim, Z. Wang, M. J. Reynolds, T. C. Mast, R. Robinson, B. R. Murphy, R. A. Karron, J. Dillner, J. T. Schiller, and D. R. Lowy. 2001. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93:284-292.
19. Inki, P., H. Larjava, K. Haapasalmi, H. M. Miettinen, R. Grenman, and M. Jalkanen. 1994. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur. J. Cell Biol. 63:43-51.
20. Jackson, T., F. M. Ellard, R. A. Ghazaleh, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, J. W. Newman, and A. M. King. 1996. Efficient infection of cells in culture by type O virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
21. Joyce, J. G., J. S. Tung, C. T. Przysiecki, J. C. Cook, E. D. Lehman, J. A. Sands, K. U. Jansen, and P. M. Keller. 1999. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 274:5810-5822.
22. Kawana, K., K. Matsumoto, H. Yoshikawa, Y. Taketani, T. Kawana, K. Yoshiike, and T. Kanda. 1998. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology 245:353-359.
23. Kirnbauer, R. 1996. Papillomavirus-like particles for serology and vaccine development. Intervirology 39:54-61.
24. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
25. Kirnbauer, R., L. Chandrachud, B. O'Neil, E. Wagner, G. Grindlay, A. Armstrong, G. McGarvie, J. Schiller, D. Lowy, and M. Campo. 1996. Virus-like particles of bovine papillomavirus type-4 in prophylactic and therapeutic immunization. Virology 219:37-44.
26. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Dürst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles J. Virol. 67:6929-6936.
27. Kost, T. A., J. A. Kessler, I. R. Patel, J. G. Gray, L. K. Overton, and S. G. Carter. 1991. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4. J. Virol. 65:3276-3283.
28. Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, and K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645-1651.
29. Litwack, E. D., J. K. Ivins, A. Kumbasar, S. Paine-Saunders, C. S. Stipp, and A. D. Lander. 1998. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn. 211:72-87.
30. Ludmerer, S. W., D. Benincasa, G. E. Mark, and N. D. Christensen. 1997. A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope. J. Virol. 71:3834-3839.
31. McLean, C. S., M. J. Churcher, J. Meinke, G. L. Smith, G. Higgins, M. Stanley, and A. C. Minson. 1990. Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J. Clin. Pathol. 43:488-492.
32. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
33. Müller, M., L. Gissmann, R. J. Cristiano, X. Y. Sun, I. H. Frazer, A. B. Jenson, A. Alonso, H. Zentgraf, and J. Zhou. 1995. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69:948-954.
34. Oksala, O., T. Salo, R. Tammi, L. Hakkinen, M. Jalkanen, P. Inki, and H. Larjava. 1995. Expression of proteoglycans and hyaluronan during wound healing. J. Histochem. Cytochem. 43:125-135.
35. Orth, G. 1987. Epidermodysplasia verruciformis, p. 199-243. In N. P. Salzman and P. M. Howley (ed.), The papovaviridae, vol. 2. The papillomaviruses. Plenum Press, New York, N.Y.
36. Roden, R., H. Greenstone, R. Kirnbauer, F. Booy, J. Joel, D. Lowy, and J. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70:5875-5883.
37. Roden, R., N. Hubbert, R. Kirnbauer, N. Christensen, D. Lowy, and J. Schiller. 1996. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 70:3298-3301.
38. Roden, R. B., A. Armstrong, P. Haderer, N. D. Christensen, N. L. Hubbert, D. R. Lowy, J. T. Schiller, and R. Kirnbauer. 1997. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. J. Virol. 71:6247-6252.
39. Roden, R. B., R. Kirnbauer, A. B. Jenson, D. R. Lowy, and J. T. Schiller. 1994. Interaction of papillomaviruses with the cell surface., J. Virol. 68:7260-7266.
40. Roden, R. B., E. M. Weissinger, D. W. Henderson, F. Booy, R. Kirnbauer, J. F. Mushinski, D. R. Lowy, and J. T. Schiller. 1994. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68:7570-7574.
41. Salzman, N. P., P. M. Howley, et al. (ed.). 1987. The papovaviridae, vol. 2. The papillomaviruses. Plenum Press, New York, N.Y.
42. Sanderson, R. D., M. T. Hinkes, and M. Bernfield. 1992. Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J. Investig. Dermatol. 99:390-396.
43. Saphire, A. C., M. D. Bobardt, Z. Zhang, G. David, and P. A. Gallay. 2001. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75:9187-9200.
44. Schiller, J. T., and M. Okun. 1996. Papillomavirus vaccines: current status and future prospects. Adv. Dermatol. 11:355-380.
45. Schmitt, A., A. Rochat, R. Zeltner, L. Borenstein, Y. Barrandon, F. O. Wettstein, and T. Iftner. 1996. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J. Virol. 70:1912-1922.
46. Selinka, H., T. Giroglou, and M. Sapp. 2002. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299:279-287.
47. Shukla, D., and P. Spear. 2001. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Investig. 108:503-510.
48. Sibbet, G., C. Romero-Graillet, G. Meneguzzi, and M. Saveria Campo. 2000. Alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J. Gen. Virol. 81:1629.
49. Slupetzky, K., S. Shafti-Keramat, P. Lenz, S. Brandt, A. Grassauer, M. Sara, and R. Kirnbauer, 2001. Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops. J. Gen. Virol. 82:2799-2804.
50. Smith, L. H., C. Foster, M. E. Hitchcock, G. S. Leiserowitz, K. Hall, R. Isseroff, N. D. Christensen, and J. W. Kreider. 1995. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J. Investig. Dermatol. 105:438-444.
51. Steinfeld, R., H. Van Den Berghe, and G. David. 1996. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol. 133:405-416.
52. Trus, B. L., R. B. Roden, H. L. Greenstone, M. Vrhel, J. T. Schiller, and F. P. Booy. 1997. Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 Å resolution. Nat. Struct. Biol. 4:413-420.
53. Unckell, F., R. E. Streeck, and M. Sapp. 1997. Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 71:2934-2939.
54. Vailly, J., L. Gagnoux-Palacios, E. Dell-Ambra, C. Romero, M. Pinola, G. Zambruno, M. De-Luca, J. P. Ortonne, and G. Meneguzzi. 1998. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther. 5:1322-1332.
55. Vinther, J., and B. Norrild. 2003. Clearance of cervical human papillomavirus infections. Int. J. Cancer 104:255-256.
56. Volpers, C., F. Unckell, P. Schirmacher, R. E. Streeck, and M. Sapp. 1995. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 69:3258-3264.
57. zur Hausen, H. 1996. Papillomavirus infection - a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.